Kingfa Science & Technology (India) Limited Fundamental Analysis
Kingfa Science & Technology (India) Limited Fundamental Analysis
Kingfa Science & Technology (India) Limited (KINGFA.NS) shows weak financial fundamentals with a PE ratio of 36.66, profit margin of 9.28%, and ROE of 17.85%. The company generates $20.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 87.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze KINGFA.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentKINGFA.NS demonstrates superior asset utilization.
Valuation Score
WeakKINGFA.NS trades at a premium to fair value.
Growth Score
ModerateKINGFA.NS shows steady but slowing expansion.
Financial Health Score
ExcellentKINGFA.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateKINGFA.NS maintains healthy but balanced margins.
Key Financial Metrics
Is KINGFA.NS Expensive or Cheap?
P/E Ratio
KINGFA.NS trades at 36.66 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, KINGFA.NS's PEG of 3.30 indicates potential overvaluation.
Price to Book
The market values Kingfa Science & Technology (India) Limited at 4.85 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 25.74 times EBITDA. This signals the market has high growth expectations.
How Well Does KINGFA.NS Make Money?
Net Profit Margin
For every $100 in sales, Kingfa Science & Technology (India) Limited keeps $9.28 as profit after all expenses.
Operating Margin
Core operations generate 12.42 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $17.85 in profit for every $100 of shareholder equity.
ROA
Kingfa Science & Technology (India) Limited generates $10.56 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Kingfa Science & Technology (India) Limited generates limited operating cash flow of $1.09B, signaling weaker underlying cash strength.
Free Cash Flow
Kingfa Science & Technology (India) Limited generates weak or negative free cash flow of $416.03M, restricting financial flexibility.
FCF Per Share
Each share generates $30.70 in free cash annually.
FCF Yield
KINGFA.NS converts 0.61% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
36.66
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.30
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.85
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.40
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.01
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.06
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.18
vs 25 benchmark
ROA
Return on assets percentage
0.11
vs 25 benchmark
ROCE
Return on capital employed
0.18
vs 25 benchmark
How KINGFA.NS Stacks Against Its Sector Peers
| Metric | KINGFA.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 36.66 | 32.56 | Worse (Expensive) |
| ROE | 17.85% | 1178.00% | Weak |
| Net Margin | 9.28% | -145.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 0.61 | Strong (Low Leverage) |
| Current Ratio | 4.06 | 3.48 | Strong Liquidity |
| ROA | 10.56% | 624.00% | Weak |
KINGFA.NS outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Kingfa Science & Technology (India) Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Commodity, Value
EPS CAGR
N/A
Industry Style: Cyclical, Commodity, Value
FCF CAGR
N/A
Industry Style: Cyclical, Commodity, Value